BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36598318)

  • 1. The driving power of the cell cycle: cyclin-dependent kinases, cyclins and their inhibitors.
    Hives M; Jurecekova J; Holeckova KH; Kliment J; Sivonova MK
    Bratisl Lek Listy; 2023; 124(4):261-266. PubMed ID: 36598318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of controlled proteolysis in cell-cycle regulation.
    Udvardy A
    Eur J Biochem; 1996 Sep; 240(2):307-13. PubMed ID: 8841392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
    Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points.
    Mateyak MK; Obaya AJ; Sedivy JM
    Mol Cell Biol; 1999 Jul; 19(7):4672-83. PubMed ID: 10373516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of mitotic events by the Cdc42 GTPase, the Clb2 cyclin and a member of the PAK kinase family.
    Tjandra H; Compton J; Kellogg D
    Curr Biol; 1998 Sep; 8(18):991-1000. PubMed ID: 9740799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours.
    Coppée F; Depoortere F; Bartek J; Ledent C; Parmentier M; Dumont JE
    Oncogene; 1998 Aug; 17(5):631-41. PubMed ID: 9704929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advances of the regulatory mechanism of cyclin, cyclin- dependent kinases and related kinase inhibitors in cell cycle progression].
    Pan J; Shang F; Ma R; Rong Y; Zhang Y
    Sheng Wu Gong Cheng Xue Bao; 2023 Apr; 39(4):1525-1547. PubMed ID: 37154321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
    Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
    Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
    Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein.
    Zhu X; Ohtsubo M; Böhmer RM; Roberts JM; Assoian RK
    J Cell Biol; 1996 Apr; 133(2):391-403. PubMed ID: 8609171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and modulation of p42/p44 MAPKs and cell cycle regulatory proteins in rat pancreas regeneration.
    Morisset J; Aliaga JC; Calvo EL; Bourassa J; Rivard N
    Am J Physiol; 1999 Nov; 277(5):G953-9. PubMed ID: 10564100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin E/Cdk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle.
    Bresnahan WA; Boldogh I; Ma T; Albrecht T; Thompson EA
    Cell Growth Differ; 1996 Oct; 7(10):1283-90. PubMed ID: 8891332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the cell cycle regulation of cdk3-associated kinase activity and the role of cdk3 in proliferation and transformation.
    Braun K; Hölzl G; Soucek T; Geisen C; Möröy T; Hengstschläger M
    Oncogene; 1998 Oct; 17(17):2259-69. PubMed ID: 9811456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of selected cell cycle regulatory proteins during aerobic and hypoxic maintenance of human ovarian carcinoma cells.
    Krtolica A; Krucher NA; Ludlow JW
    Br J Cancer; 1999 Aug; 80(12):1875-83. PubMed ID: 10471034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of endothelin-1-induced cell-cycle progression: involvement of extracellular signal-regulated kinase, protein kinase C, and phosphatidylinositol 3-kinase at distinct points.
    Suzuki E; Nagata D; Kakoki M; Hayakawa H; Goto A; Omata M; Hirata Y
    Circ Res; 1999 Mar; 84(5):611-9. PubMed ID: 10082482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation and activation of B-Myb by cyclin A-Cdk2.
    Ziebold U; Bartsch O; Marais R; Ferrari S; Klempnauer KH
    Curr Biol; 1997 Apr; 7(4):253-60. PubMed ID: 9094315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for coordinated interaction of cyclin D3 with p21 and cdk6 in directing the development of uterine stromal cell decidualization and polyploidy during implantation.
    Tan J; Raja S; Davis MK; Tawfik O; Dey SK; Das SK
    Mech Dev; 2002 Feb; 111(1-2):99-113. PubMed ID: 11804782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cell cycle kinases.
    Pines J
    Semin Cancer Biol; 1994 Aug; 5(4):305-13. PubMed ID: 7803767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
    Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
    Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.